mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.001 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |